title: Breast cancer in young women: clinicopathological features and biological specificity.
abstract: Literature data suggest that breast cancers occurring in young patients may be different from those arising in older women. In this study the clinicopathologic characteristics of 50 patients under 40 years of age were compared with those of patients aged over 60. Patients under 40 years old more frequently had a family history of breast cancer than did older patients (24% vs 17%) and had more often used oral contraceptives (29% vs 13%); on average they had experienced menarche 1 year earlier. For early onset breast carcinomas there was a higher frequency of grade 3 tumours (38% vs 17%) and oestrogen receptor negativity (46% vs 20%). In addition, in younger patients the carcinomas were mostly DNA aneuploid (78% vs 58%), with a higher proliferation rate (48% vs 26%) and more frequent c-erbB-2 overexpression (48% vs 26%) and p53 alteration (30% vs 8%). Our data demonstrate that breast cancers arising in young women have a significantly different biopathological profile from those in older patients, with a predominance of unfavourable prognostic parameters.
authors.affiliation: Institute of Pathologic Anatomy and Histology, Division of Cancer Research, University of Perugia, Perugia, Italy. anapat1@unipg.it
authors.forename: A
authors.initials: A
authors.lastname: Sidoni
authors.forename: A
authors.initials: A
authors.lastname: Cavaliere
authors.forename: G
authors.initials: G
authors.lastname: Bellezza
authors.forename: M
authors.initials: M
authors.lastname: Scheibel
authors.forename: E
authors.initials: E
authors.lastname: Bucciarelli
mesh_terms: D000328:Adult; D000367:Age Factors; D001707:Biopsy, Needle; D001943:Breast Neoplasms / Q000453:epidemiology* / Q000235:genetics / Q000473:pathology*; D016022:Case-Control Studies; D016009:Chi-Square Distribution; D005260:Female; D019398:Genes, BRCA1; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008875:Middle Aged; D009367:Neoplasm Staging; D011336:Probability; D011379:Prognosis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D012189:Retrospective Studies; D018570:Risk Assessment; D015996:Survival Rate
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases